Literature DB >> 70272

Effects of geldanamycin and its derivatives on RNA-directed DNA polymerase and infectivity of Rauscher leukemia virus.

L H Li, T D Clark, C H Cowie, K L Rinehart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70272

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

Review 1.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

2.  Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent.

Authors:  J G Supko; R L Hickman; M R Grever; L Malspeis
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

Authors:  Alexander J Bridges; Ranjit K Mehta; Sushmita Shukla; Matthew J Schipper; Theodore S Lawrence; Mukesh K Nyati
Journal:  Oncotarget       Date:  2021-05-25

Review 4.  NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones.

Authors:  David Siegel; Chao Yan; David Ross
Journal:  Biochem Pharmacol       Date:  2011-12-24       Impact factor: 6.100

5.  Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.

Authors:  Rubul Mout; Zhi-Dong Xu; Angela K H Wolf; Vincent Jo Davisson; Gotam K Jarori
Journal:  Malar J       Date:  2012-02-23       Impact factor: 2.979

Review 6.  Implications of NQO1 in cancer therapy.

Authors:  Eun-Taex Oh; Heon Joo Park
Journal:  BMB Rep       Date:  2015-11       Impact factor: 4.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.